Most interestingly, LOXL2 was found to be up-regulated in NAFLD people with T2D, and LOXL2 hepatic and circulatory amounts were linked to the advancement of histological fibrosis [71,72]. The gene discussed is LOXL2; the disease is metabolic dysfunction-associated steatotic liver disease.